Journal of Pharma and Drug Innovation

Prof Dr Alireza Heidari

Ph.D

  • Department: Faculty of Chemistry
  • University: California South University (CSU)
  • Country: United States (USA)

Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Distinguished Professor and Academic Tenure of Chemistry and also Enrico Fermi Distinguished Chair in Molecular Spectroscopy at the California South University (CSU), Irvine,California, USA. He has got his Ph.D. and D.Sc. degrees from the California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from the Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic–Structure Computations Theory from the California South University (CSU), Irvine, California, USA. His research interests include Biophysical Chemistry, Biomolecular and Biomedical Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, Synchrocyclotron Radiation, LASER, Anti–Cancer Nano Drugs, Nano Drugs Delivery, ATR–FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation & Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, Non–Covalent Interactions, Structure and Dynamics of Molecular and Biomolecular Clusters and Biomolecules, Hydrogen–Bonding and Improper, Blue–Shifting Hydrogen–Bonding, Halogen Bonding, Drug Design, Artificial Intelligence (AI) and Machine Learning (ML), Computational BioSpectroscopy, Plasmonic and Polaritonic Chemistry, Spectroscopy of Metal Clusters, Surface–Enhanced Resonance Raman Spectroscopy (SERS), Plasmonic Properties of Metal Clusters, Analysis of the Nature of Metal Cluster Interactions, etc. He has participated at more than nine hundred reputed international conferences, seminars, webinars, congresses, summits, meetings, symposiums and forums around the world as yet. Also, he possesses many published articles in Web of Science, Scopus, SCIE, SSCI, AHCI, ESCI, HEC, PMDC, PubMed, Medline and NLM. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, New Zealand, Scotland, Ireland, Netherlands, Belgium, Denmark, Luxembourg, Croatia, Romania, Greece, Russia, Estonia, Ukraine, Turkey, France, Switzerland, Germany, Sweden, Norway, Finland, Italy, Austria, Czech Republic, Hungary, Poland, South Africa, Egypt, Morocco, Brazil, Spain, Portugal, Mexico, Japan, Singapore, Malaysia, Indonesia, Thailand, Taiwan, Hong Kong, Philippines, South Korea, China, India, Kingdom of Saudi Arabia, Jordan, Qatar, United Arab Emirates, Kuwait, Oman, etc. as research fellow, sabbatical and volunteer researcher or visitor and so on heretofore. In addition, he had been visiting professor and research associate at the Delaware State University (DSU or Del State) (United States), Spelman College (United States), Sheffield Hallam University (SHU) (England), University of Freiburg (German: Albert–Ludwigs–Universität Freiburg) (UFR) (Germany), University of Padua (Italian: Università degli Studi di Padova) (UNIPD) (Italy), University of Cartagena (Spanish: Universidad de Cartagena), also called UniCartagena (Spain), Istituto Zooprofilattico Sperimentale delle Venezie (IZSVe) (Italy), Ege University or Aegean University ( Turkish : Ege Üniversitesi) (Turkey) and also Nova Southeastern University (NSU) (United States). He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industries, factories and companies. He is expert in many computer programs and programming languages. Hitherto, he has authored more than twenty books and book chapters in different fields of Chemistry. Syne, he has been awarded more than one thousand reputed international awards, prizes, scholarships, honors and grants. Heretofore, he has multiple editorial duties in many reputed international and peer–reviewed journals, books and publishers. Hitherward, he is continuous member of more than nine hundred reputed international academic–scientific–research institutes around the world. It should be noted that he is currently board member of the World Association of Theoretical and Computational Chemists (WATOC), continuous member of the American Association for Cancer Research (AACR), Philadelphia, Pennsylvania, USA, continuous member of the American Society for Biochemistry and Molecular Biology (ASBMB), Rockville, Maryland, USA, the President of the American International Standards Institute (AISI), Irvine, California, USA and also Head of Cancer Research Institute (CRI) and Director of the BioSpectroscopy Core Research Laboratory (BCRL) at the California South University (CSU), Irvine,California, USA. Furthermore, he is a World Class University Professor and Coordinator for international scientific and academic collaborations.

  • Prof. Alireza Heidari’s core research focus covers:

    • Pharmaceutical Chemistry

    • Drug Design & Development

    • Pharmacokinetics and Pharmacodynamics

    • Biospectroscopy & Biomedical Spectroscopy

    • Nanodrug Delivery Systems

    • Medicinal Chemistry

  • These scientific domains directly align with the scope of the Journal of Pharmaceutical Sciences and Drug Research.

  • He has undertaken editorial duties for numerous peer-reviewed journals in pharmaceutical sciences, drug research, and related fields.

  • He has contributed to over 900 international conferences, congresses, and symposia, frequently presenting research on:

    • Drug discovery and drug design strategies

    • Pharmaceutical analysis and spectroscopic techniques

    • Advanced nanomedicine approaches for cancer therapy

  • He holds major leadership positions that reinforce his role in pharmaceutical sciences and drug research:

    • President – American International Standards Institute (AISI), Irvine, USA

    • Head – Cancer Research Institute (CRI), CSU, Irvine, USA

    • Director – BioSpectroscopy Core Research Laboratory (BCRL), CSU, Irvine, USA

  • “A Comparative Study on Human Common Cancer Cells’ Response to Various Anti-Cancer Nano Drugs Using Synchrotron Radiation.”
    Journal of Pharmaceutical Sciences and Drug Research, Vol. 1, Issue 1, pp. 14–20, 2018.

  • “Pharmaceutical and Pharmacological Investigations of Novel Nano Drugs Delivery Systems for Targeted Cancer Therapy.”  Journal of Pharmaceutical Sciences and Drug Research, Vol. 2, Issue 2, pp. 33–40, 2019

  • Co-authored with R. Gobato on quantum chemistry simulations and natural product studies (e.g., Infrared Spectrum of Sanguinarine, 2018).
  • Computational Studies on Carbonyl and Ketene Groups in Azidoketene & Isocyanatoketene Molecules, J Appl Computat Math, 2016.

  • Molecular Dynamics & Monte Carlo Simulations for Replacement Sugars in Metabolic Diseases, J Glycobiol, 2016.

  • Graph Theoretical Analysis of Boron Nitride Nanotubes, J Appl Computat Math, 2016.